SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : InvestRight - Short Term Trading St
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeffrey L. Henken who wrote (23)9/6/1998 10:03:00 AM
From: Gerald F Bunch  Read Replies (2) of 939
 
Hello Jeff

I follow you on the ABMI & CLCK threads. I'm with you on CLCK, I think it is a diamond in the rough, with a very possible bright future. I have reservations about ABMI(no opinion yet).

I'm not a sophisticated analyst or investor by any stretch of the imagination, but CCSI looks to me like that the only revenue that is generated is the sale of stock by hype and fluffy PR's. They have had this FDA approval for a little over a year. Still no manufacturing deals and their not very likely to get one from the general looks of it.

My ex brother-in-law, who is a Dr. told me that the heel prick is by far the most reliable indicator of jaundice in an infant. To me it looks like the idea of a non-invasive test is just trying to play on the fear and sympathy of some liberals interpretation of cruelty.

Regards
GB

PS He also told me that most people in the medical profession had a terrible record of investment history <VBG>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News